Taysha Gene Therapies Inc...

NASDAQ: TSHA · Real-Time Price · USD
2.92
-0.02 (-0.68%)
At close: Aug 15, 2025, 3:59 PM

Taysha Gene Therapies Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-92.72M -86.77M -89.3M -22.77M -114.33M -118M -111.57M -215.03M -124.25M -133.53M -166.01M -160.68M -185.56M -192.61M -174.52M -142.46M -106.31M -86.6M
Depreciation & Amortization
1.16M 1.2M 1.25M 1.31M 1.34M 1.36M 1.37M 1.37M 1.31M 1.25M 1.17M 1.02M 906K 717K 492K 289K 126K 41K
Stock-Based Compensation
13.06M 13.2M 13.1M 11.86M 10.54M 9.43M 7.91M 10.04M 12.47M 14.39M 18.04M 18.89M 19.51M 19.92M 18.18M 15.24M 11.5M 6.95M
Other Working Capital
-9.45M -11.34M -9.55M -12.07M -14.15M -14.04M -15.72M 20M 26.28M 21.23M 26.32M -2.24M -5.47M 14.91M 14.17M 7.53M 8.47M -3.99M
Other Non-Cash Items
7.19M 6.24M 6.17M -50.8M -53.87M -49.86M -49.86M 45.58M 42.74M 38.88M 39.89M 4.8M 6.08M 6.08M 10.14M 10.2M 13.04M 30.05M
Deferred Income Tax
n/a n/a n/a -3.93M 97.14M 97.14M 97.14M 101.07M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-10.81M -17.32M -12.47M -14.71M -16.2M -12.72M -18.01M 14.34M 14.39M 11.24M 18.52M -6.96M 12.86M 30.08M 28.67M 20.09M 11.58M -160K
Operating Cash Flow
-82.13M -83.45M -81.24M -79.05M -75.39M -72.65M -73.02M -42.62M -53.33M -67.77M -88.39M -142.93M -146.2M -135.81M -117.04M -96.63M -71.42M -51.06M
Capital Expenditures
-413K -612K -374K -393K -3.86M -3.61M -7.37M -9.66M -9.18M -17.34M -24.87M -31.08M -32.06M -32.45M -21.55M -19.09M -15.11M -6.62M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
82K 18K 11K 7K 17K 17K 17K -51K -1.06M -1.31M -4.31M -4.5M -4M -9.25M -6.25M -12M -11.5M -9M
Investing Cash Flow
-331K -594K -363K -386K -3.84M -3.59M -7.35M -9.71M -9.24M -17.4M -24.93M -31.08M -32.06M -32.45M -21.55M -19.09M -15.11M -9.62M
Debt Repayment
n/a n/a n/a -3.85M -3.85M -3.85M -3.85M n/a n/a n/a n/a 9.98M 39.96M 39.96M 39.96M 29.98M n/a 1K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a -68K -68K -68K -68K n/a n/a n/a -1.31M -1.31M -1.31M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-70K -201K -122K -101K -116K 274K -48K -9K -188K -1.05M -775K -1.71M -1.45M -965K -874K -95.81M 71.58M 71.32M
Financial Cash Flow
222.47M 76.65M 76.68M 72.79M 206.83M 136.74M 136.39M 182.31M 41.42M 51.97M 52.1M 19.54M 49.77M 38.84M 39.08M 28.5M 272.7M 273.04M
Net Cash Flow
140.02M -7.39M -4.9M -6.63M 127.62M 60.52M 56.02M 129.97M -21.16M -33.2M -61.22M -154.47M -128.49M -129.42M -99.51M -87.22M 186.17M 212.36M
Free Cash Flow
-82.54M -84.06M -81.62M -79.44M -79.24M -76.26M -80.39M -52.28M -62.51M -85.11M -113.26M -174M -178.26M -168.26M -138.6M -115.72M -86.53M -57.68M